AtriCure, Inc.

US$58.54As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ATRCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.34%
Div yield —
ROE 2.95%
Medical Instruments & Supplies
Beta (5Y) 1.21
PE TTM 190.6
TSR TTM 69.44%
Mkt cap US$2.981B
ROIC 3.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$60
1.75%
(93.90%)
Hold 2|8|1|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.69
0.72
0.70
0.72
12.75%
7.79%
6.48%
11.25%
Revenue$M
264.1
264.4
266.4
262.7
4.96%
(0.14%)
1.84%
(2.72%)
Peers (US$2.981B)
Cap (US$)
PE
4.036B
6.541x
3.168B
422.3x
3.283B
3.750x
Capital
TTM
5Y
10Y
Leveragex
0.814
(0.271)
(0.179)
EBIT/Intx
2.186
0.112
0.112
Own earn%
51.17
186.71
168.29
Sh yield%
21.59
26.87
23.95
Owners
Insiders/Inst%
14.57
84.41
Short interest%
4.31
SBC / revenue%
4.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
2–9
$1 testx
—
Incr. ROIC%
5